These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7892769)

  • 61. Memory effects of the Ca2+ and 5-HT antagonists dotarizine and flunarizine.
    Petkov VD; Konstantinova E; Petkov VV; Belcheva S; Kehayov R; Vaglenova J
    Acta Physiol Pharmacol Bulg; 2000; 25(2):43-50. PubMed ID: 11140170
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Does nitric oxide participate in the mechanism of action of dotarizine?
    Petkov VD; Belcheva S; Konstantinova E; Petkov VV
    Acta Physiol Pharmacol Bulg; 1998; 23(3-4):93-9. PubMed ID: 10672335
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anxiolytic effects of dotarizine, a possible antimigraine drug.
    Petkov VD; Belcheva S; Konstantinova E
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):659-68. PubMed ID: 9053586
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Behavioral changes as a result of dotarizine or flunarizine influence on dopaminergic neurotransmission in the striatum.
    Petkov VD; Petkova B
    Acta Physiol Pharmacol Bulg; 1998; 23(1):21-5. PubMed ID: 10347616
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Behavioral effects of the Ca2+/5-HT antagonist dotarizine.
    Petkov VD; Belcheva S; Konstantinova E; Vaglenova J; Petkov VV
    Acta Physiol Pharmacol Bulg; 1994; 20(1):9-17. PubMed ID: 7892769
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.